PGD / PGS-NGS

Preimplantation Genetic Diagnosis (PGD) is a method which allows to eliminate the risk of passing on genetic disorders to a child before the woman gets pregnant. By examining the embryo cells, physicians are able to determine whether it has any DNA defects. For some patients it is the only possibility for having healthy offspring.

Thanks to preimplantation genetic screening within in vitro program couples, who are concerned with their children’s health, can gain peace of mind. In the course of in vitro fertilization procedure, embryos are tested for genetic disorders and only those without any defects are transferred into the uterus. The performance of PGS diagnosis provides many couples with the chance of having a healthy offspring.

2005 – performance of the first PGD in Poland!

PGS-NGS 360 – 24 chromosomes panel

PGS-NGS 360°™ – possibility of performing preimplantation genetic screening for abnormalities (aneuploidy) of all 24 chromosomes.

PGD ONE – preimplantation genetic diagnosis for monogenic diseases

Thanks to PGD ONE, carriers of genetic mutations can avoid the risk of occurrence of serious monogenic diseases in their children!

Chromosomal translocations

Preimplantation Genetic Diagnosis, PGD, allows the examination of embryo cells for translocations of various types.

NGS – next-generation sequencing

This method employs state of the art human genome sequencing techniques to examine embryos and opens up new diagnostic possibilities.

Scientific achievements – Pre-implantation Genetic Diagnosis

Proprietary methods of PGD diagnostic testing for genetic risk, supervised by Professor Krzysztof Łukaszuk PhD, MD.